S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
NYSE:RAD

Rite Aid - RAD Stock Forecast, Price & News

$3.76
-0.06 (-1.57%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$3.72
$3.97
50-Day Range
$3.19
$5.23
52-Week Range
$3.17
$11.60
Volume
2.26 million shs
Average Volume
2.54 million shs
Market Capitalization
$212.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.75

Rite Aid MarketRank™ Forecast

Analyst Rating
Reduce
1.00 Rating Score
Upside/​Downside
0.3% Downside
$3.75 Price Target
Short Interest
Bearish
19.24% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.85
Upright™ Environmental Score
News Sentiment
-0.33mentions of Rite Aid in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.15) to ($1.56) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.85 out of 5 stars

Retail/Wholesale Sector

210th out of 212 stocks

Drug Stores & Proprietary Stores Industry

5th out of 5 stocks

RAD stock logo

About Rite Aid (NYSE:RAD) Stock

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Receive RAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rite Aid and its competitors with MarketBeat's FREE daily newsletter.

RAD Stock News Headlines

CVS Health is Growing into an Integrated Healthcare Organization (RAD)
Pharmacy, insurance, and healthcare services provider CVS Health Corporation (NYSE: CVS) shares are trading near 52-week lows despite the recent rally in the
Is Walgreens Boots Alliance Earnings Miss Good For Investors? (RAD)
Integrated healthcare and pharmacy retailer Walgreens Boots Alliance Inc. (NYSE: WBA) stock recovered some sell-off losses from its fiscal Q1 2023 earnings
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Why Is Rite Aid (RAD) Down 7% Since Last Earnings Report?
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
C-Suite Transitions: Rite Aid CEO Departs Abruptly
Rite Aid CEO To Leave The Drugstore Chain
Rite Aid CEO is out, interim named
Rite Aid Names Elizabeth Burr As Interim CEO; Reaffirms FY23 Outlook
Rite Aid CEO Heyward Donigan Leaves Drugstore Chain
Rite Aid (RAD) Q1 Earnings: What to Expect
See More Headlines
Receive RAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rite Aid and its competitors with MarketBeat's FREE daily newsletter.

RAD Company Calendar

Last Earnings
12/21/2022
Today
2/05/2023
Fiscal Year End
2/28/2023
Next Earnings (Estimated)
4/13/2023

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
CUSIP
76775410
Employees
53,000
Year Founded
1968

Price Target and Rating

Average Stock Price Forecast
$3.75
High Stock Price Forecast
$4.50
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
-0.3%
Consensus Rating
Reduce
Rating Score (0-4)
1.00
Research Coverage
2 Analysts

Profitability

Net Income
$-538,480,000.00
Pretax Margin
-3.70%

Debt

Sales & Book Value

Annual Sales
$24.57 billion
Cash Flow
$8.00 per share
Book Value
($7.14) per share

Miscellaneous

Free Float
55,246,000
Market Cap
$212.52 million
Optionable
Optionable
Beta
1.22

Social Links


Key Executives

  • Elizabeth Burr
    Chief Executive Officer & Director
  • Matthew C. Schroeder
    Chief Financial Officer & Executive Vice President
  • Justin Mennen
    Chief Digital & Technology Officer
  • Jessica Kazmaier
    Chief Human Resources Officer & Executive VP
  • Andre Persaud
    Chief Retail Officer & Executive Vice President













RAD Stock - Frequently Asked Questions

Should I buy or sell Rite Aid stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last twelve months. There are currently 2 sell ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" RAD shares.
View RAD analyst ratings
or view top-rated stocks.

What is Rite Aid's stock price forecast for 2023?

2 analysts have issued twelve-month price objectives for Rite Aid's shares. Their RAD share price forecasts range from $3.00 to $4.50. On average, they predict the company's share price to reach $3.75 in the next year. This suggests that the stock has a possible downside of 0.3%.
View analysts price targets for RAD
or view top-rated stocks among Wall Street analysts.

How have RAD shares performed in 2023?

Rite Aid's stock was trading at $3.34 at the beginning of the year. Since then, RAD stock has increased by 12.6% and is now trading at $3.76.
View the best growth stocks for 2023 here
.

When is Rite Aid's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 13th 2023.
View our RAD earnings forecast
.

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) released its quarterly earnings data on Wednesday, December, 21st. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.32) by $0.18. The business had revenue of $6.08 billion for the quarter, compared to analysts' expectations of $5.94 billion. Rite Aid had a negative trailing twelve-month return on equity of 260.98% and a negative net margin of 3.73%.

When did Rite Aid's stock split?

Shares of Rite Aid reverse split on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What is Heyward Donigan's approval rating as Rite Aid's CEO?

169 employees have rated Rite Aid Chief Executive Officer Heyward Donigan on Glassdoor.com. Heyward Donigan has an approval rating of 58% among the company's employees. This puts Heyward Donigan in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Bank of America (BAC), Akorn (AKRX), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF), Mr. Cooper Group (COOP), General Electric (GE), Micron Technology (MU) and CVS Health (CVS).

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Who are Rite Aid's major shareholders?

Rite Aid's stock is owned by many different retail and institutional investors. Top institutional shareholders include SG Americas Securities LLC (0.16%), Dupont Capital Management Corp (0.06%), Investors Asset Management of Georgia Inc. GA ADV (0.04%), Bank of Montreal Can (0.02%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Heyward R Donigan and Jocelyn Z Konrad.
View institutional ownership trends
.

How do I buy shares of Rite Aid?

Shares of RAD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $3.76.

How much money does Rite Aid make?

Rite Aid (NYSE:RAD) has a market capitalization of $212.52 million and generates $24.57 billion in revenue each year. The company earns $-538,480,000.00 in net income (profit) each year or ($16.51) on an earnings per share basis.

How many employees does Rite Aid have?

The company employs 53,000 workers across the globe.

Does Rite Aid have any subsidiaries?
The following companies are subsidiares of Rite Aid: 1515 West State Street Boise Idaho LLC, 1740 Associates LLC, 4042 Warrensville Center Road—Warrensville Ohio Inc., 5277 Associates Inc., 5600 Superior Properties Inc., Advance Benefits LLC, Apex Drug Stores Inc., Ascend Health Technology LLC, Bartell Drugs, Broadview and Wallings—Broadview Heights Ohio Inc., Design Rx Holdings LLC, Design Rx LLC, Design Rxclusives LLC, Drug Palace Inc., EDC Drug Stores Inc., Eckerd Corporation, Edgehill Drugs, Elixir Holdings LLC, Elixir Insurance Company, Elixir Pharmacy LLC, Elixir Puerto Rico Inc., Elixir Rx Options LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions of Nevada LLC, Elixir Savings LLC, Envision Pharmaceutical, First Florida Insurers of Tampa LLC, GDF Inc., Genovese Drug Stores Inc., Gettysburg and Hoover-Dayton Ohio LLC, Grand River & Fenkell LLC, Harco, Harco Inc., Health Dialog, Health Dialog Services Corporation, Hunter Lane LLC, ILG – 90 B Avenue Lake Oswego LLC, JCG Holdings USA Inc., JCG PJC USA LLC, K&B Alabama Corporation, K&B Incorporated, K&B Industries, K&B Louisiana Corporation, K&B Mississippi Corporation, K&B Services Incorporated, K&B Tennessee Corporation, K&B Texas Corporation, LMW – 90B Avenue Lake Oswego Inc., Lakehurst and Broadway Corporation, Laker Software LLC, Maxi Drug Inc., Maxi Drug North Inc., Maxi Drug South L.P., Maxi Green Inc., Munson & Andrews LLC, Name Rite LLC, P.J.C. Distribution Inc., P.J.C. Realty Co. Inc., PCS Health Systems, PDS-1 Michigan Inc., PJC Lease Holdings Inc., PJC Manchester Realty LLC, PJC Peterborough Realty LLC, PJC Realty MA Inc., PJC Revere Realty LLC, PJC Special Realty Holdings Inc., PJC of Massachusetts Inc., PJC of Rhode Island Inc., PJC of Vermont Inc., Perry Distributors Inc., Perry Drug Stores Inc., RCMH LLC, RDS Detroit Inc., READ’s Inc., RediClinic, RediClinic Associates Inc., RediClinic LLC, RediClinic US LLC, RediClinic of DC LLC, RediClinic of DE LLC, RediClinic of Dallas Forth-Worth LLC, RediClinic of MD LLC, RediClinic of PA LLC, RediClinic of VA LLC, Richfield Road – Flint Michigan LLC, Rite Aid Drug Palace Inc., Rite Aid Hdqtrs. Corp., Rite Aid Hdqtrs. Funding Inc., Rite Aid Lease Management Company, Rite Aid Online Store Inc., Rite Aid Payroll Management Inc., Rite Aid Realty Corp., Rite Aid Rome Distribution Center Inc., Rite Aid Specialty Pharmacy LLC, Rite Aid Transport Inc., Rite Aid of Connecticut Inc., Rite Aid of Delaware Inc., Rite Aid of Georgia Inc., Rite Aid of Indiana Inc., Rite Aid of Kentucky Inc., Rite Aid of Maine Inc., Rite Aid of Maryland Inc., Rite Aid of Michigan Inc., Rite Aid of New Hampshire Inc., Rite Aid of New Jersey Inc., Rite Aid of New York Inc., Rite Aid of North Carolina Inc., Rite Aid of Ohio Inc., Rite Aid of Pennsylvania LLC, Rite Aid of South Carolina Inc., Rite Aid of Tennessee Inc., Rite Aid of Vermont Inc., Rite Aid of Virginia Inc., Rite Aid of Washington D.C. Inc., Rite Aid of West Virginia Inc., Rite Investments Corp., Rite Investments Corp. LLC, Rx Choice Inc., Rx Initiatives LLC, Rx USA Inc., The Bartell Drug Company, The Jean Coutu Group PJC USA Inc., The Lane Drug Company, Thrift Drug Inc., Thrifty Corporation, Thrifty PayLess Inc., and Tonic Procurement Solutions LLC.
Read More
How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The official website for the company is www.riteaid.com. The company can be reached via phone at (717) 761-2633, via email at investor@riteaid.com, or via fax at 717-975-5871.

This page (NYSE:RAD) was last updated on 2/5/2023 by MarketBeat.com Staff